Introduction
In an effort to stem their share of rising Medicaid expenditures, states are searching for innovative methods to contain the costs of health care for beneficiaries. Placing these beneficiaties in managed care arrangements has become an increasingly popular solution. In their haste to implement these programs and achieve cost savings, however, states may compromise the quality of care to which beneficiaries are entitled, specifically those with HlV! AIDS for whom potential changes in the quality of care are life-threatening. Since HN / AIDS requires a comprehensive system of treatment to ameliorate the patient's conditions and prolong life as well as prevent the spread of the epidemic, this population does not fit easily into the managed care framework of controlled access to services and preventive care. This article examines the multi-faceted issue of adequate health care for HN / AIDS patients in the context of managed care programs for state beneficiaries of Medicaid. Three potential solutions are presented: the expansion and ,stimulation of existing innovative state programs; the establishment of specific federal requirements for state Medicaid managed care programs; and the creation of a new federal program for HIV! AIDS patients. These options are evaluated on the quality of care provided, political and administrative feasibility, and cost-effectiveness. Because quality of care is botl1 a paramount concern for patients and advocacy groups and an important element in cost containment for EN/AIDS treatment, quality issues are weighted more heavily than feasibility or cost-effectiveness.
The policy recommendations presented are provisional in light of possible changes in Medicaid. This analysis assumes iliat ilie Medicaid program will continue to exist as an entitlement program jointly funded by tl1e federal and state governments. Current Congressional budget legis-GW Policy Perspectives 1996 lation, however, could fundamentally affect the system by reducing Medicaid spending or altering ilie Medicaid entitlement. Such action would shift additional costs and responsibilities to the states, though budget legislation may proVide states wider latitude in establishing programs for Medicaid beneficiaries. Whatever ilie budget scenario, federal administrators will playa smaller role in the policy debate, as states implement innovative programs.
Given federal funding uncertainty and the rising trend of managed care at the state level, establishing federal requirements for Medicaid managed care programs serving HN/AIDS patients is tl1e best policy choice. All criteria are satisfied by this option which promotes uniform standards of care and accountability to HN / AIDS patients.
Background
Since the first cases of acquired immunodeficiency syndrome (AIDS) were reported in 1981, more than 500,000 persons in ilie United States have been diagnosed with the disease, and more than half of this number have died. 1 AIDS is now the leading cause of deatl1 for Americans between the ages of 25 and 44 and claims one life every eight minutes. 2 Additionally, more than one million people are reportedly infected with human immunodeficiency virus (HN), the virus which causes AIDS.
Once infected witl1 EN, an individual can survive at least tl1ree and as many as thirteen years before contracting AIDS. For this reason, HIV / AIDS is treated as a chronic disease wiili episodes of acute illness,' Treatment requires a comprehensive and coordinated regimen of care, which can range from counseling and routine primary care visits to preSCription drugs, hospitalization, investigational treatments, home or hospice care at the late stages of the disease, and support selvices if the patient becomes disabled (i.e., transportation and housing). The duration, frequency, and cost of such treatment is difficult to predict and varies widely with each individual, but the average lifetime cost of treating a person with HIV from the time of infection until death is estimated at $119,000: 1 This cost does not include additional non-medical treatments (i.e., substance abuse, counseling, and SUppOlt services) which may also be required throughout the illness.
Given federal funding uncertainty and the rising trend of managed care at the state level, establishing federal requirements for Medicaid managed care programs serving HIV / AIDS patients is the best policy choice. 1992.12 The ability of managed care arrangements 13 to provide adequate care for people with HIV/ AIDS is questionable because managed care plans typically have a financial incentive to contain or reduce the costs of services.
14 Managed care organizations (MCOs) provide cost-effective primary and preventive care by predicting and controlling the utilization of expensive services for enrollees. These practices may conflict with the unique treatment needs of the HIV/AIDS population, as the frequency and costs of tllese services are unpredictable. 15 Managed care organizations face financial risk in providing care for HIV/AIDS populations. In order to reduce such risks, MCOs may impose limitations on the types of care provided or deny coverage for these populations altogether. For an HIV/AIDS patient, such limitations may be the difference between home treatment or hospitalization for a critical condition. 16 For this reason, health administrators and advocacy groups contend that Medicaid beneficiaries with HN I AIDS should not be subject to the same referral process or waiting period typically required in managed care plans, as these delays may fUlther jeopardize the patients' delicate healtll. These stakeholders favor unrestricted access to specialty care for people with HN / AIDS, so that the individual may choose to continue under tlle care of a specialty physician without referral from a primalY care provider, a necessalY pre-condition for non-
HN I AIDS patients in MCOs.
Advocacy groups have specifically questioned the ability of managed care organizations to provide adequate and costeffective treatment for people Witll HIV/ AIDS. In October 1995, New York City was criticized by local AIDS advocates for its proposal to place its Medicaid beneficiariesincluding approximately 25,000 people witl1 HIV / AIDS-in managed care arrangements. Based on its survey of Medicaid managed care plans in New York City, advocacy groups reported that tllese MCOs were neither knowledgeable nor experienced in dealing Witll AIDS-related illnesses.
17 In order to provide high-quality care, MCOs and other managed care arrangements must establish comprehensive, coordinated systems of care, including adequate networks of trained specialists and a broad array of services uniquely required during the stages of HN / AIDS. Such systems of care should also coordinate witll public health agencies, health care providers, and communitybased and voluntary organizations that proVide both medical and non-medical services. IS
Options
Proposed policy options are: expanding and stimulating existing innovative programs, establishing specific federal guidelines for Medicaid managed care programs, and creating a new federal program for HN / AIDS patients.
Option 1: Expand and Stimulate Existing Innovative Programs
The current vehicles for innovations for Medicaid managed care at the state level have been proviSions in the Medicaid Act (known as the Section 1115 "Research and Demonstration," 1915Cb) "Freedom of Choice," and 1915(c) Homeand Community-based waivers), which enable states to design unique programs for Medicaid beneficiaries by suspending some of the statutOlY requirements of the Medicaid program.!9 Since the first cases of acquired immunodeficiency syndrome (AIDS) were reported in 1981, more than 500,000 persons in the United States have been diagnosed with the disease, and more than half of this number have died.
In establishing waiver demonstration programs, many states have focused on the "healthy" sectors of the populationnamely women and children-since studies of some managed care programs have shown some improvements in cost-effective, high-quality care for this population. 20 Most approved waiver programs have exempted beneficiaries with HIV / AIDS; however, several states have targeted these beneficiaries through 1915(c) "Home-and CommunityBased" waivers which enable states to provide a variety of home-and community-based care to Medicaid beneficiaries under a capitated system.
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! Under the traditional fee-for-service model, these selvices would be provided in the hospital or a nursing home, which are often more costly settings.
Since both the 1915(b) and (c) waiver programs have potential applicability for HIV / AIDS patients, and, in some cases, already provide services for these populations, the Healtl1 Care Financing Administration (HCFA), tl1e federal agency which oversees Medicaid, could offer further incentives to states (i.e., special grants or expedited waiver approval) to expand current waiver programs or establish new waiver programs which target people with HN / AIDS. In fact, HCFA has already drafted a 1915(c) waiver prototype which outlines the requisite information states need for the waiver approval. State use of this standardized form will reduce the application time and resources, streamline tlle application process, and expedite waiver approval. Additionally, the quality standards used to evaluate these programs could be applied to larger, state-wide programs which serve HN / AIDS patients. 27 In general, bOtll groups support the improvement of care for people with HIV / AIDS through managed care organizations, but favor gradual implementation based on previous experience and thorough program evaluation.
These requirements would specifically address the concerns of people with HIV/AIDS, including the types of services offered, the proposed provider network, the referral process for specialty care, and adequate and accurate program evaluation. The primalY focus of such requirements should be tl1e quality of care for HN / AIDS patients. Additionally, these requirements may compel states to address regional and state-specific ()bstacles to care.
Option 3: Create a New Federal Program for mv / AIDS Patients.
The Office of National AIDS Policy has proposed a jointlyfunded capitated program which would use existing state and federal funds from tl1e Ryan White CARE Act and Medicaid to provide care for HN/AIDS patients. 28 Presently, the Ryan White CARE Act prohibits grantees from using funds to finance inpatient services for people wiili HIV / AIDS.l9 Thus, while grantees can provide funding for outpatient services, iliese organizations must rely on their own resources to cover ilie costs of inpatient care.
Ey establishing a joint program, government administrators, community-based organizations, and advocacy groups could establish a more uniform, comprehensive system of care. This option would require coordination between HCFA and ilie Healili Resources Services Administration, tl1e federal agency which allocates Ryan White CARE Act funding.
3D These agencies would then establish a funding system for Ryan White grantees and state governments that would keep ilie funding streams separate, so iliat Ryan White money would be used only for outpatient services.
Criteria
In identifying and evaluating ilie options that will provide me best and most cost-effective care for people with HIV/AIDS, administrative agencies, advocacy groups, and providers have identified several criteria iliat must be satisfied. The most desirable policy option must provide highquality care and be politically and administratively feasible and cost-effective.
I. Quality of Care
Advocacy groups and community-based organizations maintain a strong commitment to improving tl1e quality of care for people with HIV/AIDS, and will not support any option which reduces the standard of care for this population. Advocates and HIV / AIDS patients evaluate quality based on the follOWing factors: an established continuum of care; knowledgeable healili care personnel; access to specialty services; and quality assurance through comprehensive program monitoring.
The quality of care under managed care arrangements,1 is of paramount concern for people with HIV / AIDS for two reasons. First, advocacy groups and administrators worry about ilie lack of previous experience on tl1e part of managed care organizations (MCOs) in providing care to people with HIV / AIDS. Second, under capitated Medicaid programs, MCOs may reduce tl1e number of available services in an effort to reduce the costs of care.
Placement of Medicaid beneficiaries witl1 HIV / AIDS in managed care arrangements should be accomplished in a manner least dismptive to ilie existing care relationships for iliese patients. 3l Effective, high-quality care of HIV/AIDS patients requires continuous monitoring by the proVider of tl1e patient's progress and treatment plan. Any care arrangement which results in forced change of provider may dismpt this continuum of care.
Placement of Medicaid beneficiaries
with HIV/ AIDS in managed care arrangements should be accomplished in a manner least disruptive to the existing care relationships for these patients.
Care providers must be knowledgeable about ilie various approaches to HIV / AIDS treatment and prevention. Due to the protean nature of the disease, tl1e standard of care for the treatment of HIV / AIDS changes rapidly, and often relies upon experimental intelventions, including tl1e "offlabel" use of prescription drugs. 33 MCOs should establish broad networks of trained specialists with knowledge of HIV / AIDS and ilie various ways in which tl1e disease presents itself. Community-based providers and advocacy groups tl1at provide essential non-medical services should also be included in this network.
Access to care, specifically specialty care, is an important issue; HIV / AIDS patients must be able to receive care when necessary in order to effectively treat their disease. If essential selvices are not provided through ilie managed care arrangement, HIV / AIDS patients will be forced to either pay for ilie treatment tl1emselves or seek care from charity organizations, community-based organizations, 01' oilier public providers. Healili plans should include ilie broad array of treatment and support services required by HIV/ AIDS patients during ilieir illness. 34 Care should be included in a variety of settings: inpatient care of opportunistic infections, home-based infusion therapy, 01' hospice care, for example.
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In order to ensure that the above criteria are being met, states should evaluate managed care arrangements using basic outcome measures: tl1e incidence of opportunistic infections in people wiili HIV, 
Since Medicaid is a joint federal-state program, the support of the Health Care
Financing Administration (HCFA) is fundamental to the success of a policy.
Support from advocacy groups and community-based organiZations is also essential, as these organizations provide or coordinate social services for HN / AIDS patients. Since many of these organizations are also Ryan White grantees, they may contribute valuable financial and administrative support to effective care for HN / AIDS patients. The interests of d1ese groups are best represented by two advocacy groups, the Gay Men's Healili Crisis (GMHC) and ilie AIDS
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Action Council (AAC).
Administrative feasibility is an important sub-criterion on several levels. Evaluation of administt'ative feasibility discloses the lengili of time and amount of funding necessary to implement the program, the legal and procedural obstacles which must be addressed prior to implementation, and ilie appropriate balance between program requirements and existing resources. Great differences among state Medicaid programs increase an alternative'S effect on resource allocation, proVider participation and celtification, beneficiary enrollment, and program evaluation.
m. Cost-Effectiveness
The cost-effectiveness criterion determines whether provided services are comparable or better than those previously provided as well as actual costs and benefits involved. An important component in evaluating the alternative for possible cost savings is accurate and iliorough program evaluation. 38 Any alternative must provide a framework for accurate data collection and program evaluation to determine the costs of services and evaluate fue financial benefits of managed care for HN/AIDS populations. The impOltance of measuring the financial impact of managed care arrangements is amplified by the quality of care criterion: quality will yield lower long-term costs of care for HN / AIDS patients.
Evaluation of Options Option 1: Expand and Stimulate Existing Innovative Programs
This option addresses the quality of care criterion by applying fue current standards for waiver proposals to innovative programs as well. These standards would require states to establish a continuum of care, provide knowledgeable health care personnel, enable access to services, and promote quality assurance through program monitoring. However, while the use of such standards would establish some degree of uniformity among waiver programs, the option would encourage further variability among state Medicaid programs. Not all states possess the resources to expand existing programs or create innovative pilot programs; these states would instead choose to continue to care for HN / AIDS patients under the current Medicaid benefits package. Thus, the quality of care for Medicaid beneficiaries would continue to vary widely across state boundaries.
Both the existing waiver programs and the innovative pilots included in this option have received support from federal and state administrative agencies, the Office of National AIDS Policy, advocacy groups, and communitybased organizations. States particularly enjoy the flexibility in designing special programs to meet the unique needs of their HN / AIDS populations. Additionally, other stakeholder groups have applauded states' efforts to focus on HN / AIDS patients.
The option's use of existing program standards and a prototype waiver to streamline the application process and expedite waiver approval would relieve some of the administrative burden of evaluating waiver proposals. However, federal administrators would still be required to evaluate states' innovative pilots on a case-by-case basis, a process which would severely strain federal resources. Additionally, this option would require state administrative agencies to supply additional evaluative data, some of which is (in some states) not currently available.
The option's overall impact on Medicaid expenditures is difficult to determine. The Office of National AIDS Policy, federal and state administrative agencies, advocac), groups, and community-based organizations are not convinced that managed care arrangements can prOVide cost-effective treatment, even for "healtllY" populations. Although capitation under managed care can provide immediate cost savings, if managed care limits costly but necessary selvices (i.e. hospitalization), the use of these services may negate any short-term savings. This situation would be especially problematic for HN/AIDS patients because such utilization control eliminates uniform standards of care.
Option 2: Establish Specific Federal Requirements for State Medicaid Managed Care Programs
Establishing federal requirements would best address the issue of quality of care by ensuring that states provide a continuum of care and a provider network of knowledgeable health care personnel, access to specialty care, and quality assurance through program monitoring. This option would eliminate the disparity among state programs by establishing unifonll standards for all Medicaid managed care programs d1at include HN/AIDS patients. Although states would still have the flexibility to design innovative waiver programs, ac1ministrators have to adhere to specific guidelines for HN/AIDS patients.
This option has received support from several governmental and interest group stakeholders. Enabling all interest groups to participate in the process would ensure that tl1e final requirements would be acceptable to all stakeholders. State administrative agencies, however, may resent additional requirements for an already bureaucratic program. In the event that states resist further requirements, federal 14 administrators could provide additional financial and technical SUppOlt to enable states to meet tl1e new requirements.
With regard to administrative feasibility, this option would require sophisticated data collection at the state and federal levels and more thorough evaluations of state waiver proposals by HCFA administrators. Additional resources from bod1 d1e federal and state governments would be needed if more focused compliance overSight is reqUired. These costs could be offset by interest groups' earlier effOlts to draft possible guidelines which could then be used as a starting point for federal requirements. Also, federal technical support to states could alleviate some of the administrative burden of compliance with the requirements.
As previously mentioned, costs are heightened at the federal level by increased administrative oversight and at the state level by the requirement of more thorough data collection and policy evaluation. States may incur additional costs in providing additional benefits necessaty to satisfy the requirements. These costs could be balanced by savings generated by managed care arrangements. Also, evaluation data would be valuable in assessing the impact of managed care arrangements on Medicaid beneficiaries and implementing cost-effective measures. Thus, administrators should realize tl1at the short-term costs associated with the option could outweigh the long-term benefits, of which the most impOltant is an improvement in tl1e quality of care for Medicaid beneficiaries with HN / AIDS.
[Closts are heightened at the federal level by increased administrative oversight and at the state level by the requirement of more thorough data collection and policy evaluation. 
Recommendation
The establishment of specific federal requirements for state Medicaid managed care programs is the preferred policy option for several reasons. First, federal requirements established by all stakeholders would specifically address the primary issue of high-quality care for HN / AIDS patients, and would ensure that the special needs of this population are met by states' Medicaid managed care programs. Specifically, the requirements would address each of the components of the quality of care criterion: an established continuum of care; knowledgeable health care personnel; access to specialty services; and quality assurances through comprehensive program monitoting. These standards would eliminate the disparity among state Medicaid managed care programs while allOwing states to retain flexibility and autonomy in designing such programs.
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In addition to satisfying the quality of care criterion, the recommended policy option is also administratively feasi- 
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shifting Medicaid beneficiaries into managed care arrangements at a rapid pace. Although preliminary data suggest that such arrangements can proVide adequate and costeffective preventive and primaty care services for "healthy" Medicaid beneficiaries, their ability to provide the same standard of care for HIV / AIDS patients is questionable. Because managed care plans have a financial irtcentive to limit the utilization of specialty services, such arrangements could seriously compromise the quality of care for HIV / AIDS patients with potentially dangerous results.
Although the waiver process proVides states with the flexibility to design irtnovative and experimental solutions to increasing Medicaid expenditures, the wide variability among state Medicaid programs prevents the establishment of uniform standards of care for Medicaid beneficiaries with HIV / AIDS. Such standards are necessary to ensure a mirtimallevel of benefits for HIV/AIDS patients.
Differences among states' programs also inhibits accurate data collection. Unless this issue is fully addressed, neither federal nor state administrators will be able to determine tl1e costs and benefits of managed care programs for HIV! AIDS populations.
Establishing federal requirements presents the best opportunity to improve the quality of care for HIV / AIDS patients. Medicaid.) 31Altll0Ugh Medicaid managed care arrangements come in many forms, two primaty models (as defined by the Kaiser Commission on tlle Future of Medicaid) are fee-for-service primary care case management (PCCM), and full-risk plans. PCCM systems designate a specific provider, usually the patient's primary care physician, as a "gatekeeper" by approving and monitoring all covered services. In the case of an HN / AIDS patient, the case manager would provide basic primary care services and would approve any specialty care in exchange for a monthly case management fee, and a separate fee for each service provided. Since PCCM providers do not assume financial risk for the provision of such services, tlley do not have sU'ong incentives to conu'ol costs. Under a fulldsk or "fully capitated" plan, the state Medicaid program contracts with a corporate entity which provides a set of services through a designated provider network for a fixed monthly fee, The corporation may shift some of the financial risk by subcontracting with hospitals and other providers, Thus, both the corporate entity and the providers have an incentive to contain health care costs, An HN / AIDS patient would be required to receive primary care from a list of providers whose referral would also be required for specialty care, In some cases, the patient would be permitted to see a specialist outside of the plan, but only on a fee-far-service basis, Additionally, the plan may exclude certain types of experimental treatment from coverage or limit benefits such as the length of hospital stays, 
